© The Author(s) 2018. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
The Neuroimmunology and Neuroinflammation Editorial Office would like to report an abbreviation-related error in the published article.
The first sentence of paragraph 2 in Introduction part "Approximately 2/3 of patients with epilepsy become seizure-free following correct diagnosis and on appropriate treatment with antiepileptic drugs automated external defibrillator (AED)" has been replaced by "Approximately 2/3 of patients with epilepsy become seizure-free following correct diagnosis and on appropriate treatment with antiepileptic drugs (AED)".
During the production, there was a mistake in matching up the abbreviation "AED" with corresponding words and it has been corrected. We apologize for any inconvenience caused to the readers by this change. The change does not affect the scientific results.
The original article was published on 27 Sep 2017.
1. Alkhidze M, Lomidze G, Kasradze S, Tsiskaridze A. Characteristics and predictive biomarkers of drug resistant epilepsy -- study in Georgia. Neuroimmunol Neuroinflammation 2017;4:191-8.DOI
Neuroimmunology and Neuroinflammation Editorial Office . Erratum: Characteristics and predictive biomarkers of drug resistant epilepsy -- study in Georgia. Neuroimmunol Neuroinflammation 2018;5:35. http://dx.doi.org/10.20517/2347-8659.2018.54
Quantities of Full-Text Views Each Month
Quantities of PDF Downloads Each Month